Related Experiment Videos
[Management of hypertensive patients in private practice]
J L Imbs1, M Welsch, D Stephan
1Service d'hypertension et des maladies vasculaires, CHRU, Strasbourg.
Insights
General practitioners manage mild to moderate arterial hypertension by initiating treatment for permanent hypertension and correcting risk factors. They select single-drug therapies, adjusting dosage or combining medications if initial treatment is ineffective.
Area of Science:
- Cardiology
- General Practice
- Pharmacology
Context:
- Arterial hypertension management in private practice.
- Focus on preventing severe, organ-damaging hypertensive disease.
- General practitioner's role in hypertension control.
Purpose:
- Outline a 3-step approach for general practitioners to manage mild to moderate arterial hypertension.
- Guide drug selection based on benefit/risk, comorbidities, and patient acceptability.
- Provide strategies for optimizing treatment when initial therapy fails.
Summary:
- Step 1: Initiate treatment for confirmed permanent hypertension and address risk factors.
- Step 2: Select initial monotherapy from diuretics, beta-blockers, ACE inhibitors, or calcium antagonists, optimizing dosage for efficacy and tolerability.
- Step 3: If treatment fails, verify adherence and dosage, then consider alternative monotherapy or low-dose combination therapy.
Impact:
- Standardizes hypertension management in primary care settings.
- Aims to improve patient outcomes by preventing severe hypertensive complications.
- Emphasizes individualized treatment selection and optimization for better medication adherence and effectiveness.
Abstract:
In private practice mild or moderate arterial hypertension is controlled primarily to prevent the development of a severe, organ-damaging hypertensive disease. The general practitioner's approach to management proceeds in 3 steps. 1) He must decide to initiate a treatment after obtaining sufficient evidence that the hypertension is permanent and after starting to correct the associated risk factors. 2) He must select a single-drug initial treatment among the four families of antihypertensive medications, viz.: diuretics, beta-blockers, angiotensin-converting enzyme inhibitors and calcium antagonists. The selection is based on the information available concerning the benefit/risk ratio of the preferred drug, its interactions with the pathologies that are often associated with hypertension, and its acceptability. Finding for each patient the optimal dosage with maximum effectiveness and minimum undesirable side-effects is of prime importance. 3) If this initial treatment fails, the practitioner must first make sure that his prescription was optimal in dosage and compliance. If this was the case, he must make a choice between another single-drug therapy and a combination therapy, using by preference two synergistic drugs in low doses.